According to the data from the Third China National Stroke Registry (CNSR-III), low baseline serum ALB levels (<3.5 g/dL) arose as a risk factor associated with poorer outcomes and mortality in acute ischemic stroke (AIS) or transient ischemic attack (TIA) patients at 3-month follow-up [45]. This evidence concerns the gene ALB and stroke disorder.